vs
Side-by-side financial comparison of ASHFORD HOSPITALITY TRUST INC (AHT) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $259.0M, roughly 1.1× ASHFORD HOSPITALITY TRUST INC). Bio-Techne runs the higher net margin — 12.8% vs -26.8%, a 39.6% gap on every dollar of revenue. On growth, ASHFORD HOSPITALITY TRUST INC posted the faster year-over-year revenue change (-6.0% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -7.7%).
Ashford Hospitality Trust Inc is a U.S.-headquartered real estate investment trust focused on upper-upscale full-service hotel properties across key U.S. urban, suburban and resort markets. Its portfolio holds assets under top global hospitality brands, serving business and leisure travelers, with a focus on long-term value growth and stable shareholder returns.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
AHT vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $259.0M | $295.9M |
| Net Profit | $-69.3M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | -2.6% | 18.4% |
| Net Margin | -26.8% | 12.8% |
| Revenue YoY | -6.0% | -6.4% |
| Net Profit YoY | 44.2% | 68.3% |
| EPS (diluted) | $-12.85 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $259.0M | $295.9M | ||
| Q3 25 | $266.1M | — | ||
| Q2 25 | $302.0M | $317.0M | ||
| Q1 25 | $277.4M | $316.2M | ||
| Q4 24 | $275.5M | $297.0M | ||
| Q3 24 | $276.6M | $289.5M | ||
| Q2 24 | $316.5M | $306.1M | ||
| Q1 24 | $303.9M | $303.4M |
| Q4 25 | $-69.3M | $38.0M | ||
| Q3 25 | $-60.1M | — | ||
| Q2 25 | $-30.4M | $-17.7M | ||
| Q1 25 | $-20.0M | $22.6M | ||
| Q4 24 | $-124.2M | $34.9M | ||
| Q3 24 | $-57.9M | $33.6M | ||
| Q2 24 | $50.3M | $40.6M | ||
| Q1 24 | $71.6M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | -2.6% | 18.4% | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 16.3% | -7.5% | ||
| Q1 25 | 22.2% | 12.2% | ||
| Q4 24 | -17.8% | 16.0% | ||
| Q3 24 | 7.3% | 13.8% | ||
| Q2 24 | 42.8% | 15.0% | ||
| Q1 24 | 50.2% | 22.1% |
| Q4 25 | -26.8% | 12.8% | ||
| Q3 25 | -22.6% | — | ||
| Q2 25 | -10.1% | -5.6% | ||
| Q1 25 | -7.2% | 7.1% | ||
| Q4 24 | -45.1% | 11.7% | ||
| Q3 24 | -20.9% | 11.6% | ||
| Q2 24 | 15.9% | 13.3% | ||
| Q1 24 | 23.5% | 16.2% |
| Q4 25 | $-12.85 | $0.24 | ||
| Q3 25 | $-11.35 | — | ||
| Q2 25 | $-6.88 | $-0.11 | ||
| Q1 25 | $-4.91 | $0.14 | ||
| Q4 24 | $-13.64 | $0.22 | ||
| Q3 24 | $-12.39 | $0.21 | ||
| Q2 24 | $2.50 | $0.26 | ||
| Q1 24 | $5.99 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $66.1M | $172.9M |
| Total DebtLower is stronger | $2.5B | $260.0M |
| Stockholders' EquityBook value | $-626.4M | $2.0B |
| Total Assets | $2.8B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.1M | $172.9M | ||
| Q3 25 | $81.9M | — | ||
| Q2 25 | $100.0M | $162.2M | ||
| Q1 25 | $85.8M | $140.7M | ||
| Q4 24 | $112.9M | $177.5M | ||
| Q3 24 | $119.7M | $187.5M | ||
| Q2 24 | $121.8M | $152.9M | ||
| Q1 24 | $111.1M | $145.3M |
| Q4 25 | $2.5B | $260.0M | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.6B | $346.0M | ||
| Q1 25 | $2.7B | $330.0M | ||
| Q4 24 | $2.6B | $300.0M | ||
| Q3 24 | $2.7B | $300.0M | ||
| Q2 24 | $2.8B | $319.0M | ||
| Q1 24 | $2.9B | $389.0M |
| Q4 25 | $-626.4M | $2.0B | ||
| Q3 25 | $-548.7M | — | ||
| Q2 25 | $-485.5M | $1.9B | ||
| Q1 25 | $-446.1M | $2.0B | ||
| Q4 24 | $-419.2M | $2.1B | ||
| Q3 24 | $-288.4M | $2.1B | ||
| Q2 24 | $-225.9M | $2.1B | ||
| Q1 24 | $-276.8M | $2.0B |
| Q4 25 | $2.8B | $2.5B | ||
| Q3 25 | $3.0B | — | ||
| Q2 25 | $3.1B | $2.6B | ||
| Q1 25 | $3.1B | $2.6B | ||
| Q4 24 | $3.2B | $2.7B | ||
| Q3 24 | $3.3B | $2.7B | ||
| Q2 24 | $3.3B | $2.7B | ||
| Q1 24 | $3.5B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | — |
| Free Cash FlowOCF − Capex | $-86.8M | — |
| FCF MarginFCF / Revenue | -33.5% | — |
| Capex IntensityCapex / Revenue | 27.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-135.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.7M | — | ||
| Q3 25 | $5.5M | — | ||
| Q2 25 | $16.3M | $98.2M | ||
| Q1 25 | $-25.0M | $41.1M | ||
| Q4 24 | $-23.6M | $84.3M | ||
| Q3 24 | $795.0K | $63.9M | ||
| Q2 24 | $8.0M | $75.5M | ||
| Q1 24 | $-46.5M | $81.0M |
| Q4 25 | $-86.8M | — | ||
| Q3 25 | $-226.0K | — | ||
| Q2 25 | $-3.6M | $93.3M | ||
| Q1 25 | $-44.8M | $31.0M | ||
| Q4 24 | $-131.6M | $77.5M | ||
| Q3 24 | $-21.8M | $54.7M | ||
| Q2 24 | $-22.9M | $57.5M | ||
| Q1 24 | $-80.4M | $64.5M |
| Q4 25 | -33.5% | — | ||
| Q3 25 | -0.1% | — | ||
| Q2 25 | -1.2% | 29.4% | ||
| Q1 25 | -16.2% | 9.8% | ||
| Q4 24 | -47.8% | 26.1% | ||
| Q3 24 | -7.9% | 18.9% | ||
| Q2 24 | -7.2% | 18.8% | ||
| Q1 24 | -26.5% | 21.3% |
| Q4 25 | 27.5% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 6.6% | 1.5% | ||
| Q1 25 | 7.2% | 3.2% | ||
| Q4 24 | 39.2% | 2.3% | ||
| Q3 24 | 8.2% | 3.2% | ||
| Q2 24 | 9.8% | 5.9% | ||
| Q1 24 | 11.2% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | 0.16× | 1.86× | ||
| Q1 24 | -0.65× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHT
| Occupancy | $190.2M | 73% |
| Food And Beverage | $51.8M | 20% |
| Hotel Other | $16.6M | 6% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
